ATE496120T1 - Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit - Google Patents

Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit

Info

Publication number
ATE496120T1
ATE496120T1 AT02728354T AT02728354T ATE496120T1 AT E496120 T1 ATE496120 T1 AT E496120T1 AT 02728354 T AT02728354 T AT 02728354T AT 02728354 T AT02728354 T AT 02728354T AT E496120 T1 ATE496120 T1 AT E496120T1
Authority
AT
Austria
Prior art keywords
adenovirus
lysis
concentration
same process
process unit
Prior art date
Application number
AT02728354T
Other languages
English (en)
Inventor
Thomas Monica
Erik Whiteley
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE496120T1 publication Critical patent/ATE496120T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C12N1/066—Lysis of microorganisms by physical processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02728354T 2001-03-01 2002-02-27 Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit ATE496120T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27203401P 2001-03-01 2001-03-01
PCT/US2002/005596 WO2002070673A1 (en) 2001-03-01 2002-02-27 Concentration and lysis of adenovirus-infected cells in a single unit operations

Publications (1)

Publication Number Publication Date
ATE496120T1 true ATE496120T1 (de) 2011-02-15

Family

ID=23038121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02728354T ATE496120T1 (de) 2001-03-01 2002-02-27 Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit

Country Status (10)

Country Link
US (1) US6773909B2 (de)
EP (1) EP1363997B1 (de)
JP (2) JP4559026B2 (de)
AR (1) AR032921A1 (de)
AT (1) ATE496120T1 (de)
DE (1) DE60238970D1 (de)
ES (1) ES2355065T3 (de)
PE (1) PE20020960A1 (de)
UY (1) UY27191A1 (de)
WO (1) WO2002070673A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1922308A (zh) 2004-02-23 2007-02-28 克鲁塞尔荷兰公司 病毒纯化方法
US7592139B2 (en) 2004-09-24 2009-09-22 Sandia National Laboratories High temperature flow-through device for rapid solubilization and analysis
CA2602944C (en) 2005-04-11 2015-08-11 Crucell Holland B.V. Virus purification using ultrafiltration
US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
CN114176049B (zh) * 2022-01-20 2023-01-31 河南农业大学 一种同时提高室内繁育棉铃虫齿唇姬蜂出蜂率和雌虫数量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721120A (en) * 1996-10-02 1998-02-24 Merck & Co., Inc. Method of disrupting cultured cells using an impinging jet device

Also Published As

Publication number Publication date
US6773909B2 (en) 2004-08-10
US20030049829A1 (en) 2003-03-13
EP1363997A1 (de) 2003-11-26
DE60238970D1 (de) 2011-03-03
EP1363997B1 (de) 2011-01-19
WO2002070673A1 (en) 2002-09-12
ES2355065T3 (es) 2011-03-22
AR032921A1 (es) 2003-12-03
UY27191A1 (es) 2002-10-31
JP2009189370A (ja) 2009-08-27
JP4559026B2 (ja) 2010-10-06
PE20020960A1 (es) 2002-11-14
JP2004533814A (ja) 2004-11-11

Similar Documents

Publication Publication Date Title
EP1383379A4 (de) Wiederherstellung von karzinom-unterdrückenden funktionen bei neoplastischen zellen durch dna-hypomethylierung
AU2003234323A8 (en) Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
DE60329983D1 (de) Wachsestersynthase-dna-sequenz, protein und verwendungen davon
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60134866D1 (de) Verwendung von imidazochinolinaminen als adjuvantien in dna-impfung
WO2003087306A8 (en) Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
AU2003243151A1 (en) Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
EP1517606A4 (de) Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 193p1e1b
EP1551324A4 (de) Flüssigkeitsbearbeitungssets und organisatoren dafür
EP1377611A4 (de) Muteine des durch hypoxie induzierbaren faktors alpha und verwendungsverfahren dafür
DE502004000891D1 (de) Organosilylfunktionalisierte partikel und deren herstellung
DK1537140T3 (da) Nukleinsyre og tilsvarende protein betegnet 161P2F10B, der er anvendelige i behandling og detektering af cancer
DK1372719T3 (da) Nukleinsyre og tilsvarende protein betegnet 125P5C8, der er anvendelig i behandling og påvisning af cancer
ATE496120T1 (de) Konzentration und lyse von adenovirus-infizierten zellen in derselben prozesseinheit
IL141539A0 (en) Dna molecules and cells transfected therewith
EP1425289A4 (de) Neue nukleinsäure- und polypeptidmoleküle
EP1456418A4 (de) Identifizierung neuer polymorpher orte im menschlichen mglur8-gen und verwendungen davon
BR0212523A2 (pt) Ácido nucléico, polipeptídeo purificado e seus usos
GB0303524D0 (en) Improvements in and relating to the handling of dna
AU2002258785A1 (en) Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
DE602004005748D1 (de) Nitrooxy-derivate von carvedilol und anderen betablockern als antihypertensiva
IL158860A0 (en) Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer and pharmaceutical compositions containing the same
EP1071749A4 (de) Neues lrsg-protein und nukleinsäuremoleküle sowie deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties